Kallikrein 11 anticorps (AA 201-282) (Biotin)

N° du produit ABIN704293

Cet anticorps Lapin Polyclonal détecte spécifiquement Kallikrein 11 dans WB, ELISA, IHC (p) et IHC (fro). Il présente une réactivité envers Humain.

Aperçu rapide pour Kallikrein 11 anticorps (AA 201-282) (Biotin) (ABIN704293)

Antigène: Kallikrein 11 (KLK11)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Kallikrein 11 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-Kallikrein 11 anticorps (Biotin)

Épitope: AA 201-282

Réactivité croisée: Humain

Homologie: Mouse,Rat,Dog

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human KLK11

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur Kallikrein 11

Antigène: Kallikrein 11 (KLK11)

Autre désignation: KLK11

Sujet:

Synonyms: Hippostasin, hK11, KLK 11, KLK-11, kallikrein 11, Kallikrein 11 isoform 1 preproprotein, Kallikrein 11 isoform 2 precursor, Kallikrein 11 precursor, kallikrein related peptidase 11, KLK 11, KLK11, Protease serine 20 trypsin like, Protease serine trypsin like, PRSS20, Serine protease 20, TLSP, Trypsin like protease, KLK11_HUMAN.

Background: Kallikrein 11 has two alternative splicing isoforms, known as the brain type and prostate type. Elevated serum levels of hK11 have been found in 70 % of women with ovarian cancer and in 60 % of men with prostate cancer. Analysis of this biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.

ID gène: 11012

Pathways: Système du Complément